Theravance Biopharma logo
Theravance Biopharma TBPH
$ 9.64 -3.31%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Theravance Biopharma ROE Ratio 2011-2024 | TBPH

Annual ROE Ratio Theravance Biopharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-4.0 -2.35 9.46 91.53 105.64 417.77 -247.79 -54.44 -74.97 -81.8 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
417.77 -247.79 15.91

Quarterly ROE Ratio Theravance Biopharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-24.7 -21.5 -18.55 -15.18 175.55 369.93 377.85 200.46 209.92 30.1 45.2 59.17 68.94 82.28 85.53 91.53 101.6 103.46 100.55 105.64 173.61 262.71 324.03 417.77 245.02 71.75 -64.92 -247.79 -191.55 -143.19 -99.12 -54.44 -53.66 -63.43 -69.53 -74.97 -78.72 -78.06 -78.56 -81.8 199.16 459.1 707.85 917.43 658.67 417.53 188.87 - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
917.43 -247.79 123.22